PKM and hepatocellular carcinoma: Studies have shown that testes-specific protease 50 (TSP50) can maintain a low level of PKM2 tetramers by acetylating the K433 site of PKM2, thereby inhibiting its activity and promoting aerobic glycolysis and tumor progression in HCC (51).